about
Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties.Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkersGlucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet.Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approachesEarly cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker.Therapeutic and nutraceutical potential of rosmarinic acid-Cytoprotective properties and pharmacokinetic profile.Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Spatial memory impairments in a prediabetic rat model.Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice.Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes.Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathyCharacterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral deliveryWeight loss achieved by bariatric surgery modifies high-density lipoprotein subfractions and low-density lipoprotein oxidation towards atheroprotectionTherapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of DiabetesCrescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric DietThe yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disordersDiet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy
P50
Q30399061-28AB31DD-3F73-4310-994C-7963CA11988DQ33746612-8D2C2E47-0943-464A-9F54-72D4A8D16D32Q33852238-9CDF15EC-2BD6-4015-A86E-1A2A5B4FFCD2Q36106482-D3190C1D-7888-472C-9A50-C26E9A050A98Q36690425-C1A75E7E-90E6-4C1E-A2FB-696E9354C88CQ38538405-03E46B0A-E444-4E6D-B089-E8D7A9C37CCEQ38550745-96448ABE-6E43-4840-BB60-A63FF7471BF6Q44258350-32A8020F-FD0B-4714-B4ED-E48180F6F264Q48412582-3C6DEC48-0F23-4D23-9C01-7EE0AEBB5293Q55317221-E598E5E2-831E-4B45-B350-3AA5C06F5398Q57052505-73CF7FE7-27F2-47A2-8DAF-FF348A4D4476Q57570733-03C39CCB-82B0-411D-AE42-D2A0D73F72AAQ57813204-7ECBE202-8E81-4DC8-81D3-97FAD149052AQ61814333-A2182722-CDAC-4802-9F1B-E85E36167456Q90692152-0EC6F90C-7079-4ED6-BD27-CA1C9AB695FDQ91327952-51C0EABB-52B7-4570-B914-8610D32065C0Q92813959-6466E6DB-D918-414C-B8BC-0102EA5AC14C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sara Nunes
@ast
Sara Nunes
@en
Sara Nunes
@es
Sara Nunes
@nl
Sara Nunes
@sl
type
label
Sara Nunes
@ast
Sara Nunes
@en
Sara Nunes
@es
Sara Nunes
@nl
Sara Nunes
@sl
altLabel
Nunes S
@en
prefLabel
Sara Nunes
@ast
Sara Nunes
@en
Sara Nunes
@es
Sara Nunes
@nl
Sara Nunes
@sl
P1053
G-5141-2017
P106
P1153
36574173900
P21
P31
P3829
P496
0000-0002-0240-9059